β-Thalassemia major (β-TM) is an inherited disease and efforts have been made in several countries to reduce the number of affected births. In the present study, we aimed to evaluate the Iranian thalassemia prevention program, considered to be an important program in the region. The time period of the present study ranges from 2007–2009, during which new thalassemic births and the relevant causes were evaluated throughout the country. A cross-sectional analytical study was conducted at the Iranian Blood Transfusion Organization (IBTO), Tehran, Iran. A questionnaire was forwarded to all blood centers of the IBTO so as to obtain information about the new cases of thalassemia and the causes of these thalassemic births. Provincial thalassemia s...
Background: Beta-thalassemia minor and thalassemia major are an autosomal recessive disease with hyp...
Introduction: Beta-thalassemia is the most common hereditary disease in Iran. More than two million ...
There is large variation in the molecular genetics and clinical features of hemoglobinopathies in Ir...
Background: Iran is one of the countries located on “the thalassemia belt ” with a significant annua...
Thalassemia is one of the genetic diseases for which there are only a few successful prevention prot...
BACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherite...
BACKGROUND AND OBJECTIVE: The premarital screening of β-thalassemia was performed all over the count...
Background: Iran is a country located on the thalassemic belt of the globe. Investigating such issue...
Background&Objective: Thalassemia is the most common genetic disorder, 2-3 million carriers and 20 t...
BACKGROUND: β-Thalassaemia is a common genetic blood disorder in the Middle Eastern region. Mandator...
Background and purpose : bata thlassemia is the most common monogenic disorders in Iran. The gene fr...
This Paper is to describe the economic burden of thalassemia as a major health problem in thalassemi...
Background Iran is one of the countries located on the “thalassemia belt ” and a thalassemia prevent...
Background: Thalassemia is a common inherited anemia; and population-level screening followed by mol...
<p><strong>Objective:</strong> Pre-natal diagnosis is the most effected way to prevent genetic disea...
Background: Beta-thalassemia minor and thalassemia major are an autosomal recessive disease with hyp...
Introduction: Beta-thalassemia is the most common hereditary disease in Iran. More than two million ...
There is large variation in the molecular genetics and clinical features of hemoglobinopathies in Ir...
Background: Iran is one of the countries located on “the thalassemia belt ” with a significant annua...
Thalassemia is one of the genetic diseases for which there are only a few successful prevention prot...
BACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherite...
BACKGROUND AND OBJECTIVE: The premarital screening of β-thalassemia was performed all over the count...
Background: Iran is a country located on the thalassemic belt of the globe. Investigating such issue...
Background&Objective: Thalassemia is the most common genetic disorder, 2-3 million carriers and 20 t...
BACKGROUND: β-Thalassaemia is a common genetic blood disorder in the Middle Eastern region. Mandator...
Background and purpose : bata thlassemia is the most common monogenic disorders in Iran. The gene fr...
This Paper is to describe the economic burden of thalassemia as a major health problem in thalassemi...
Background Iran is one of the countries located on the “thalassemia belt ” and a thalassemia prevent...
Background: Thalassemia is a common inherited anemia; and population-level screening followed by mol...
<p><strong>Objective:</strong> Pre-natal diagnosis is the most effected way to prevent genetic disea...
Background: Beta-thalassemia minor and thalassemia major are an autosomal recessive disease with hyp...
Introduction: Beta-thalassemia is the most common hereditary disease in Iran. More than two million ...
There is large variation in the molecular genetics and clinical features of hemoglobinopathies in Ir...